Ambu A/S (AMBBY)
OTCMKTS
· Delayed Price · Currency is USD
16.89
0.00 (0.00%)
At close: Apr 28, 2025
Ambu A/S Revenue
Ambu A/S had revenue of 1.51B DKK in the quarter ending December 31, 2024, with 20.41% growth. This brings the company's revenue in the last twelve months to 5.65B, up 15.32% year-over-year. In the fiscal year ending September 30, 2024, Ambu A/S had annual revenue of 5.39B with 12.90% growth.
Revenue (ttm)
5.65B DKK
Revenue Growth
+15.32%
P/S Ratio
6.25
Revenue / Employee
1.09M DKK
Employees
5,196
Market Cap
4.90B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 5.39B | 616.00M | 12.90% |
| Sep 30, 2023 | 4.78B | 331.00M | 7.45% |
| Sep 30, 2022 | 4.44B | 431.00M | 10.74% |
| Sep 30, 2021 | 4.01B | 446.00M | 12.50% |
| Sep 30, 2020 | 3.57B | 747.00M | 26.49% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Ambu A/S News
- 3 months ago - Ambu AS (AMBFF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus
- 5 months ago - Ambu A/S goes ex dividend tomorrow - Seeking Alpha
- 6 months ago - Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Ambu A/S reports 2023/24 financial year results - Seeking Alpha
- 6 months ago - Ambu A/S 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 8 months ago - Ambu A/S (AMBFF) Q3 2024 Earnings Call Transcript Highlights: Strong Organic Growth and ... - GuruFocus
- 1 year ago - Ambu A/S (AMBFF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript - Seeking Alpha